Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.93 |
| ▸ | MEN1 | O00255 | 1/20 | 0.93 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.93 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.93 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.93 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA3 | P07451 | 2/20 | 0.57 |
| ▸ | CA4 | P22748 | 2/20 | 0.57 |
| ▸ | CA6 | P23280 | 2/20 | 0.57 |
| ▸ | CA5A | P35218 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.57 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2444301 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Bromide SCHEMBL3895282 | 1.00 | — | — | |
| Dodecylamine SCHEMBL129158 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Pentadecylamine SCHEMBL3049228 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Bromide SCHEMBL1257604 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Hexadecylamine SCHEMBL126964 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Bromide SCHEMBL3106064 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Bromide SCHEMBL5557202 | 1.00 | — | — | |
| Bromide SCHEMBL11380806 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Icosylamine SCHEMBL609205 | 1.00 | DNM1 (1.00) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250344704-A1 | SEED TREATMENT METHODS AND COMPOSITIONS FOR IMPROVING PLANT TRAITS AND YIELD | ANDES AG INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250288594-A1 | PHARMACEUTICAL DOSAGE FORMS AND METHODS OF USE | EMALEX BIOSCIENCES, INC. | 2025-09-18 | — | — | US | claimed |
| EP-4527499-A1 | A CATALYST FOR HYDROGENATION OF UNSATURATED HYDROCARBONS AND A METHOD FOR PREPARATION THEREOF | Indian Oil Corporation Limited (IN) | 2025-03-26 | — | — | EP | claimed |
| US-20250091037-A1 | CATALYST FOR HYDROGENATION OF UNSATURATED HYDROCARBONS AND A METHOD FOR PREPARATION THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2025-03-20 | — | — | US | claimed |
| CN-114050273-B | Modified graphene oxide, composite material, GDL and preparation method thereof | 东风汽车集团股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-112974796-B | Composite structure of single silver nanowire and preparation method and application thereof | 南京大学 | 2022-06-21 | — | — | CN | claimed |
| US-20220144716-A1 | SEED TREATMENT METHODS AND COMPOSITIONS FOR IMPROVING PLANT TRAITS AND YIELD | ANDES AG, INC. | 2022-05-12 | — | — | US | claimed |
| CN-114449895-A | Novel seed treatment methods and compositions for improving plant traits and yield | 安第斯农业公司 | 2022-05-06 | — | — | CN | claimed |
| EP-3956276-A1 | NOVEL SEED TREATMENT METHODS AND COMPOSITIONS FOR IMPROVING PLANT TRAITS AND YIELD | Andes Ag, Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| CN-114050273-A | Modified graphene oxide, composite material, GDL and preparation method thereof | 东风汽车集团股份有限公司 | 2022-02-15 | — | — | CN | claimed |
| US-5597560-A | NON-STEROID ANTIINFLAMMATORY AGENT AND ANTIBIOTIC MIXTURE; SHELF LIFE | LABORATORIOS CUSI, S.A. (ES) | 1997-01-28 | — | — | US | claimed |
| EP-0661055-A1 | Pharmaceutical formulation containing clobetasone and tobramycin and applications thereof | LABORATORIOS CUSI, S.A. (ES) | 1995-07-05 | — | — | EP | claimed |
| EP-0592348-A1 | Pharmaceutical formulation comprised of polymyxin-trimethoprim and an anti-inflammatory drug for ophthalmic and optic topical use | LABORATORIOS CUSI, S.A. (ES) | 1994-04-13 | — | — | EP | claimed |
| US-4680235-A | Recording material for ink jet printing | RICOH COMPANY, LTD. (JP) | 1987-07-14 | — | — | US | claimed |
| US-4634580-A | PRE-REDUCTION OF IRON | URANIUM PECHINEY (FR) | 1987-01-06 | — | — | US | claimed |
| US-4469685-A | PLANT EXTRACTS | THE KITASATO INSTITUTE (JP) | 1984-09-04 | — | — | US | claimed |
| US-4456597-A | SOLVENT EXTRACTION WITH WATER, AND FILTRATION | THE KITASATO INSTITUTE (JP) | 1984-06-26 | — | — | US | claimed |
| US-4442087-A | EXTRACT OF ARTEMISIA | THE KITASATO INSTITUTE (JP) | 1984-04-10 | — | — | US | claimed |
| US-4419349-A | PLANT EXTRACTS | THE KITASATO INSTITUTE (JP) | 1983-12-06 | — | — | US | claimed |
| EP-0061793-A1 | Method for preparing a chromogen reactive for determining the serum iron concentration and binding power, and the chromogen reactive obtained thereby | CHEMICAL LABORATORIES S.r.l. (IT) | 1982-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250288594-A1 | PHARMACEUTICAL DOSAGE FORMS AND METHODS OF USE | MC2R, PTGDR, HTR5A | DNM1 2489/4885TSHR 135/4885MEN1 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.